Form 4 for PCRX Pacira BioSciences, Inc.
Accepted 2025-01-06 00:00:00 ET · period of report 2024-12-31 · accession 0001396814-25-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-01-06 | 2024-12-31 | PCRX | GAUGLER DARYL | COO | A - Grant | $16.01 | +243.54 | 115.4K | +0.2% | +$3,899 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-12-31 | A | A | 243.54 | $16.01 | 115,443.49 | D | — | — |